Beyond obesity and type 2 diabetes, retatrutide is under investigation for related conditions such as nonalcoholic steatohepatitis (NASH)
Video: Indicaties en werkzaamheid: Behandeling van obesitas: Tijdens het klinische onderzoek in fase II verloren patinten in de hoogste doseringsgroep (12 mg) gemiddeld 24,2% van hun gewicht na 48 weken, en sommige patinten verloren meer dan 30%
Semaglutide is not suitable for all patients seeking weight loss
The trials also showed that a proportion of patients treated with tirzepatide experienced significant categorical improvements in OSA severity, with some moving from severe to moderate, moderate to mild, or achieving AHI levels below diagnostic thresholds
You'll receive either pre-filled pens (if your protocol uses them) or multi-dose vials with disposable needles, depending on your prescription
(The patients fingers are depicted.) The diagnosis is oral melanoma